Search research articles
Contact Us
Filters
Showing results (281-290 of 347) with videos related to
Page
of 35
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2020
Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study
Soo-Zin Kim-Wanner, Yassen Assenov, Mridul B Nair, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
Olaf Penack, Thomas Luft, Christophe Peczynski, et al.
Nature Communications
|
March 8, 2016
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration
Georg Gdynia, Sven W Sauer, Jürgen Kopitz, et al.
Nature Cancer
|
October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial
Nora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Blood
|
January 6, 2023
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
Nicola Giesen, Manik Chatterjee, Christof Scheid, et al.
Leukemia
|
November 4, 2021
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Lisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, et al.
International Journal of Cancer
|
April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
Umar Khalid, Milena Simovic, Linda A Hammann, et al.
Leukemia
|
May 25, 2021
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
Hans Salwender, Ahmet Elmaagacli, Maximilian Merz, et al.
Hematology (Amsterdam, Netherlands)
|
February 26, 2024
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial
Hans Salwender, Niels Weinhold, Axel Benner, et al.
Acta Neuropathologica
|
December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Alfa H C Bai, Till Milde, Marc Remke, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 347) with videos related to
Sort By:
Page
of 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2020
Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study
Soo-Zin Kim-Wanner, Yassen Assenov, Mridul B Nair, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
Olaf Penack, Thomas Luft, Christophe Peczynski, et al.
Nature Communications
|
March 8, 2016
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration
Georg Gdynia, Sven W Sauer, Jürgen Kopitz, et al.
Nature Cancer
|
October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial
Nora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Blood
|
January 6, 2023
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
Nicola Giesen, Manik Chatterjee, Christof Scheid, et al.
Leukemia
|
November 4, 2021
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Lisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, et al.
International Journal of Cancer
|
April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
Umar Khalid, Milena Simovic, Linda A Hammann, et al.
Leukemia
|
May 25, 2021
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
Hans Salwender, Ahmet Elmaagacli, Maximilian Merz, et al.
Hematology (Amsterdam, Netherlands)
|
February 26, 2024
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial
Hans Salwender, Niels Weinhold, Axel Benner, et al.
Acta Neuropathologica
|
December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Alfa H C Bai, Till Milde, Marc Remke, et al.
Page
of 35